128 related articles for article (PubMed ID: 29224328)
1. [Clinical characteristics and prognostic analysis of monoclonal IgM-related AL amyloidosis].
Mao YY; Feng J; Meng Q; Shen KN; Cao XX; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):989-992. PubMed ID: 29224328
[No Abstract] [Full Text] [Related]
2. European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis.
Sachchithanantham S; Roussel M; Palladini G; Klersy C; Mahmood S; Venner CP; Gibbs S; Gillmore J; Lachmann H; Hawkins PN; Jaccard A; Merlini G; Wechalekar AD
J Clin Oncol; 2016 Jun; 34(17):2037-45. PubMed ID: 27114592
[TBL] [Abstract][Full Text] [Related]
3. AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entity.
Palladini G; Russo P; Bosoni T; Sarais G; Lavatelli F; Foli A; Bragotti LZ; Perfetti V; Obici L; Bergesio F; Albertini R; Moratti R; Merlini G
Clin Lymphoma Myeloma; 2009 Mar; 9(1):80-3. PubMed ID: 19362981
[TBL] [Abstract][Full Text] [Related]
4. Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexamethasone.
Palladini G; Foli A; Russo P; Milani P; Obici L; Lavatelli F; Merlini G
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):143-5. PubMed ID: 21454217
[TBL] [Abstract][Full Text] [Related]
5. Transplantation for IgM amyloidosis and IgM myeloma.
Gertz MA; Hayman SR; Buadi FK
Clin Lymphoma Myeloma; 2009 Mar; 9(1):77-9. PubMed ID: 19362980
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and treatment responses in IgM-related AL amyloidosis.
Sissoko M; Sanchorawala V; Seldin D; Sworder B; Angelino K; Broce M; Berk J; Sloan JM
Amyloid; 2015; 22(4):229-35. PubMed ID: 26488936
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal IgM-related AL amyloidosis.
Milani P; Merlini G
Best Pract Res Clin Haematol; 2016 Jun; 29(2):241-248. PubMed ID: 27825470
[TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation and IgM amyloidosis.
Valente M; Roy V; Lacy MQ; Dispenzieri A; Gertz MA
Leuk Lymphoma; 2006 Jun; 47(6):1006-12. PubMed ID: 16840189
[TBL] [Abstract][Full Text] [Related]
9. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
[TBL] [Abstract][Full Text] [Related]
13. IgM amyloidosis: clinical features in therapeutic outcomes.
Gertz MA; Buadi FK; Hayman SR
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):146-8. PubMed ID: 21454218
[TBL] [Abstract][Full Text] [Related]
14. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
[TBL] [Abstract][Full Text] [Related]
15. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
16. IgM AL amyloidosis due to B cell lymphoproliferative disorder: efficacy of high-dose melphalan followed by autologous stem cell transplantation.
Gono T; Matsuda M; Shimojima Y; Ishii W; Yamamoto K; Koyama J; Sakashita K; Koike K; Itoh S; Isaka T; Ikeda S
Amyloid; 2004 Jun; 11(2):130-5. PubMed ID: 15478470
[TBL] [Abstract][Full Text] [Related]
17. [Nephrotic syndrome caused by AL amyloidosis, associated with lambda IgM monoclonal gammapathy].
Navas-Parejo A; Ortega MJ; Montes J; Cerezo S
Nefrologia; 2003; 23(1):92-3. PubMed ID: 12708384
[No Abstract] [Full Text] [Related]
18. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
[TBL] [Abstract][Full Text] [Related]
19. Nephrotic syndrome associated with generalized amyloidosis and IgM-monoclonal proteinemia.
Hirose H; Takemura Y; Honma S; Asano K; Fukui T; Satoh T; Sugiura H
Jpn J Med; 1991; 30(2):130-4. PubMed ID: 1907693
[TBL] [Abstract][Full Text] [Related]
20. Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.
Sidiqi MH; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Leung N; Gonsalves WI; Kapoor P; Kourelis TV; Hogan WJ; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):e108-e111. PubMed ID: 30529461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]